Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amphastar Pharmaceuticals, Inc. Director's Dealing 2015

Dec 18, 2015

10216_dirs_2015-12-17_a95d3a93-62ba-4dc9-8b60-60fb42894282.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2015-12-16

Reporting Person: Zhou Rong (EVP, Production)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-16 Common Stock S 772 $14.2901 Disposed 25460 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 99668 Indirect
Common Stock 5000 Indirect

Footnotes

F1: The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.

F2: The shares are held of record by the reporting person's spouse.